248 related articles for article (PubMed ID: 27196814)
1. Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region.
Al Hammadi A; Al-Sheikh A; Ammoury A; Ghosn S; Gisondi P; Hamadah I; Kibbi AG; Shirazy K
J Dermatolog Treat; 2017 Mar; 28(2):129-135. PubMed ID: 27196814
[TBL] [Abstract][Full Text] [Related]
2. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
[TBL] [Abstract][Full Text] [Related]
3. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis Trends and Practice Gaps.
Gottlieb AB; Greb JE; Goldminz AM
Dermatol Clin; 2016 Jul; 34(3):235-42. PubMed ID: 27363878
[TBL] [Abstract][Full Text] [Related]
5. Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis.
Blauvelt A; Armstrong AW; Krueger GG
J Drugs Dermatol; 2015 Aug; 14(8):805-12. PubMed ID: 26267724
[TBL] [Abstract][Full Text] [Related]
6. Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals.
López-Estebaranz JL; de la Cueva-Dobao P; de la Torre Fraga C; Galán Gutiérrez M; González Guerra E; Mollet Sánchez J; Belinchón Romero I
Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):631-642. PubMed ID: 29891209
[TBL] [Abstract][Full Text] [Related]
7. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
Stiff KM; Glines KR; Porter CL; Cline A; Feldman SR
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1209-1218. PubMed ID: 30449211
[TBL] [Abstract][Full Text] [Related]
8. Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.
Abdulghani M; Al Sheik A; Alkhawajah M; Ammoury A; Behrens F; Benchikhi H; Benkaidali I; Doss N; El Gendy A; Mokhtar I; Odendaal D; Raboobee N; Thaçi D; Weiss R; Whitaker D
J Int Med Res; 2011; 39(5):1573-88. PubMed ID: 22117959
[TBL] [Abstract][Full Text] [Related]
9. [Biologics. New drugs, new adverse reactions].
Prinz JC
Hautarzt; 2010 Aug; 61(8):668-75. PubMed ID: 20585746
[TBL] [Abstract][Full Text] [Related]
10. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
Armstrong AW; Robertson AD; Wu J; Schupp C; Lebwohl MG
JAMA Dermatol; 2013 Oct; 149(10):1180-5. PubMed ID: 23945732
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
Feldman SR; Regnier SA; Chirilov A; Hey F; Gilloteau I; Cella D
J Am Acad Dermatol; 2019 Jun; 80(6):1650-1657. PubMed ID: 30703461
[TBL] [Abstract][Full Text] [Related]
12. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
[TBL] [Abstract][Full Text] [Related]
13. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
14. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
Tveit KS; Duvetorp A; Østergaard M; Skov L; Danielsen K; Iversen L; Seifert O
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
[TBL] [Abstract][Full Text] [Related]
15. Management of childhood psoriasis in France. A national survey among general practitioners, pediatricians, and dermatologists.
Mahé E; Bursztejn AC; Phan A; Corgibet F; Beauchet A
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193624
[TBL] [Abstract][Full Text] [Related]
16. Use of biologic agents in pediatric psoriasis.
Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
18. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.
Guibal F; Iversen L; Puig L; Strohal R; Williams P
Curr Med Res Opin; 2009 Dec; 25(12):2835-43. PubMed ID: 19916728
[TBL] [Abstract][Full Text] [Related]
19. Expert recommendations on treating psoriasis in special circumstances.
Carrascosa JM; Belinchón I; de-la-Cueva P; Izu R; Luelmo J; Ruiz-Villaverde R
Actas Dermosifiliogr; 2015 May; 106(4):292-309. PubMed ID: 25595327
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
